Please provide your email address to receive an email when new articles are posted on . The most common ophthalmic procedure is an intravitreal injection, with more than 10 million per year performed ...
Jose Martinez, MD: When we assess patients and we’re trying to consider whether to use anti-VEGF [anti-vascular endothelial growth factor], one thing we consider is their ability to come back and see ...
Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 ...
Please provide your email address to receive an email when new articles are posted on . Two-year results of an ongoing study show that intravitreal aflibercept injections in eyes with baseline ...
Intravitreal injections with aflibercept (Eylea) don't improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for ...
Early pars plana vitrectomy (PPV) using modern surgical tools demonstrated promising outcomes in patients who developed endophthalmitis after cataract surgery or intravitreal injection. Most regained ...
LONG BEACH, Calif. -- Methotrexate, during and after surgery for primary retinal detachment, has produced "amazing" early results in preventing proliferative vitreoretinopathy (PVR), according to ...
A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...
A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results